Role of fibroblast growth factors and their receptors in pancreatic cancer and chronic pancreatitis

Pancreas

Volumn 17, Issue 2, 1998, Pages 169-175

  Kornmann, Marko ^b   Beger, Hans G ^a   Korc, M ^b,c  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Medical Science I C240   (United States)

Author keywords

Chronic pancreatitis; Fibroblast growth factor; Fibroblast growth factor receptor; Pancreatic cancer; Review

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; TYROSINE KINASE RECEPTOR;

ARTICLE; CHRONIC PANCREATITIS; HUMAN; IMMUNOPATHOGENESIS; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECEPTOR AFFINITY; RECEPTOR DENSITY;

EID: 0031844173     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199808000-00010     Document Type: Article

References (71)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997;47:5-27.
2. Aaronson SA. Growth factors and cancer. Science 1991;254:1146-53.
3. Almoguera C, Shibata D, Forrester K, Martin J, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988;53:549-54.
4. Bos JL. Ras oncogenes in human cancer: a review. Cancer Res 1989;49:4682-9.
5. Barton CM, Staddon SL, Hughes CM, et al. Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. Br J Cancer 1991;64:1076-82.
6. Graham C, Yamanaka Y, Friess H, et al. p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitis. Cancer Lett 1993;69:151-60.
7. Hahn SA, Schutte M, Hoque ATMS, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996;271:350-60.
8. Korc M. Growth factors and pancreatic cancer. In: Beger HG, Büchler MW, Schoenberg MH, eds. Cancer of the pancreas. Ulm, Germany: Universitätsverlag Ulm GmbH, 1996:135-12.
9. Holt S. Chronic pancreatitis. Smith Med J 1993;86:201-7.
10. Niederau C, Niederau MC, Heintges T, Lüthen R. Epidemiology: Relation between chronic pancreatitis and pancreatic carcinoma. In: Beger HG, Büchler MW, Schoenberg MH, eds. Cancer of the pancreas. Ulm, Germany: Universitätsverlag Ulm GmbH, 1996: 9-15.
11. Friess H, Korc M, Büchler MW. Growth factors and growth factor receptors in chronic pancreatitis. In: Beger HG, Büchler MW, Schoenberg MH, eds. Cancer of the pancreas. Ulm, Germany: Universitätsverlag Ulm GmbH, 1996;143-50.
12. Burgess WH, Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 1989;58:575-606.
13. Basilico C, Moscatelli D. The FGF family of growth factors and oncogenes. Adv Cancer Res 1992;59:115-65.
14. Fernig DG, Gallagher JF. Fibroblast growth factors and their receptors: An information network controlling tissue growth, morphogenesis and repair. Prog Growth Factor Res 1994;5:353-77.
15. Friesel RE, Maciag T. Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J 1995;9:919-25.
16. Burgess WH, Winkles JA. The fibroblast growth factor family: multifunctional regulators of cell proliferation. In: Pusztai L, Lewis CE, Yap E, eds. Cell proliferation in cancer, regulatory mechanisms of neoplastic cell growth. New York: Oxford University Press, 1996:154-217.
17. Smallwood PM, Munoz-Sanjuan I, Tong P, et al. Fibroblast growth factor (FGF) homologous factors: New members of the FGF family implicated in nervous system development. Proc Natl Acad Sci USA 1996;93:9850-7.
18. Coulier F, Pontarotti P, Roubin R, Hartung H, Goldfarb M, Birnbaum D. Of worms and men: An evolutionary perspective on the fibroblast growth factor (FGF) and FGF receptor families. J Mol Evol 1997;44:43-57.
19. Emoto H, Tagashira S, Mattei M-G, et al. Structure and expression of human fibroblast growth factor-10. J Biol Chem 1997;272: 23191-4.
20. Leung HY, Gullick WJ, Lemoine NR. Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer. Int J Cancer 1994;59:667-75.
21. Beauchamp RD, Lyons RM, Yang EY, Coffey RJ Jr, Moses HL. Expression of and response to growth regulatory peptides by two human pancretic carcinoma cell lines. Pancreas 1990;5:369-89.
22. Kornmann M, Ishiwata T, Beger HG, Korc M. Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions. Oncogene 1997;15:1417-24.
23. Siddiqi I, Funatomi H, Kobrin MS, Friess H, Büchler MW, Korc M. Increased expression of keratinocyte growth factor in human pancreatic cancer. Biochem Biophys Res Commun 1995;215:309-15.
24. Kouhara H, Koga M, Kasayama S, Tanaka A, Kishimoto T, Sato B. Transforming activity of a newly cloned androgen-induced growth factor. Oncogene 1994;9:455-62.
25. MacArthur CA, Lawshe A, Shankar DB, Heikinheimo M, Shackleford GM. FGF-8 isoforms differ in NIH3T3 cell transforming potential. Cell Growth Diff 1995;6:817-25.
26. Santos-Ocampo S, Colvin JS, Chellaiah A, Ornitz DM. Expression and biological activity of mouse fibroblast growth factor-9. J Biol Chem 1996;271:1726-31.
27. Miyamoto M, Naruo K-I, Seko C, Matsumoto S, Kondo T, Kurokawa T. Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property. Mol Cell Biol 1993;13:4251-9.
28. Mason IJ. The ins and outs of fibroblast growth factors. Cell 1995; 78:547-52.
29. Klagsburn M, Baird A. A dual receptor system is required for basic fibroblast growth factor activity. Cell 1991;67:229-31.
30. Givol D, Yayon A. Complexity of FGF receptors: genetic basis for structural diversity and functional specifity. FASEB J 1992;6: 3362-9.
31. Jaye M, Schlessinger J, Dionne CA. Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochim Biophys Acta 1992;1135:185-99.
32. Johnson DE, Williams LT. Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 1993;60:1-41.
33. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990;61:203-12.
34. Kouhara H, Hadari YR, Spivak-Kroizman T, et al. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell 1997;89:693-702.
35. Penault-Llorca F, Bertucci F, Adelaide J, et al. Expression of FGF and FGF receptor genes in human breast cancer. Int J Cancer 1995;61:170-6.
36. Yamanaka Y, Friess H, Büchler M, et al. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res 1993;53:5289-96.
37. Ishiwata T, Friess H, Büchler MW, Korc M. KGF and its receptor are co-expressed in human pancreatic cancer. Pancreas 1996;13: 440.
38. Kornmann M, Arber N, Korc M. Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum. J Clin Invest 1998;101:344-52.
39. Gambarini AG, Miyamoto CA, Lima GA, Nader HB, Dietrich CP. Mitogenic activity of acidic fibroblast growth factor is enhanced by highly sulfated oligosaccarides derived from heparin and heparan sulfate. Mol Cell Biochem 1993;124:1219-29.
40. Bates B, Hardin J, Zhan X, Drickamer K, Goldfarb M. Biosynthesis of human fibroblast growth factor-5. Mol Cell Biol 1991;11: 1840-5.
41. Werner S, Roth WK, Bates B, Goldfarb M, Hofschneider PH. Fibroblast growth factor 5 proto-oncogene is expressed in normal human fibroblasts and induced by serum growth factors. Oncogene 1991;6:2137-44.
42. Brauchle M, Angermeyer K, Hübner G, Werner S. Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts. Oncogene 1994;9:3199-204.
43. Chedid M, Rubin JS, Csaky KG, Aaronson SA. Regulation of keratinocyte growth factor gene expression by interleukin 1. J Biol Chem 1994;269:10753-7.
44. Le Panse R, Bouchard B, Lebreton C, Coulomb B. Modulation of keratinocyte growth factor (KGF) mRNA expression in human dermal fibroblasts grown in monolayer or within a collagen matrix. Exp Dermatol 1996;5:108-14.
45. Korc M, Chandrasekar B, Yamanaka Y, Friess H, Büchler M, Beger HG. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor α. J Clin Invest 1992;90:1352-60.
46. Ebert M, Yokoyama M, Friess H, Kobrin MS, Büchler MW, Korc M. Induction of platelet-derived growth factor α and β chains and over-expression of their receptors in human pancreatic cancer. Int J Cancer 1995;62:529-35.
47. Dlugosz AA, Cheng C, Denning MF, Dempley PJ, Coffey RJ, Yuspa SH. Keratinocyte growth factor receptor ligands induce transforming growth factor a expression and activate the epidermal growth factor receptor signaling pathway in cultured epidermal keratinocytes. Cell Growth Diff 1994;5:1283-92.
48. Funatomi H, Itakura J, Ishiwata T, et al. Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy. Int J Cancer 1997;72:512-7.
49. Otonoski T, Beattie GM, Rubin JS, Lopez AD, Baird A, Hayek A. Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes 1994;43:947-53.
50. Bergmann U, Funatomi H, Yokoyama M, Beger HG, Korc M. Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res 1995;55:2007-11.
51. Bergmann U, Funatomi H, Kornmann M, Beger HG, Korc M. Increased expression of insulin receptor substrate-1 in human pancreatic cancer. Biochem Biophys Res Commun 1996;220:886-90.
52. Partanen J, Makela TP, Eerola E, et al. FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J 1991;10:1347-54.
53. Friess H, Kobrin M, Korc M. Acidic and basic fibroblast growth factors and their receptors are expressed in the human pancreas. Pancreas 1992;7:737.
54. Kobrin MS, Yamanaka Y, Friess H, Lopez ME, Korc M. Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomas. Cancer Res 1993;53:4741-4.
55. Yamaguchi F, Saya H, Brunner JM, Morrison RS. Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc Natl Acad Sci USA 1994;91:484-8.
56. Yan GC, Wang F, Fukabori Y, Sussman D, Hou JZ, McKeehan WL. Expression and transforming activity of a variant of the heparin-binding fibroblast growth factor receptor (flg) gene resulting from splicing of the alpha exon at an alternate 3′ acceptor site. Biochem Biophys Res Commun 1992;183:423-30.
57. Avivi A, Yayon A, Givol D. A novel form of FGF receptor-3 using an alternative exon in the immunoglobulin domain III. FEBS Lett 1993;330:249-52.
58. Gilbert E, Del Gatto F, Champion-Arnaud P, Gesnel M-C, Breathnach R. Control of BEK and K-SAM splice sites in alternative splicing of the fibroblast growth factor receptor 2 pre-mRNA. Mol Cell Biol 1993;13:5461-8.
59. Orr-Urtreger A, Bedford MT, Burakova T, et al. Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR-2). Dev Biol 1993;158:475-86.
60. Yan G, Fukabori Y, McBride G, Nikolaropolous S, McKeehan WL. Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol Cell Biol 1993;13:4513-22.
61. Alarid ET, Rubin FS, Young P, et al. Keratinocyte growth factor functions in epithelial induction during seminal vesicle development. Proc Natl Acad Sci USA 1994;91:1074-8.
62. Ornitz DM, Xu J, Colvin JS, et al. Receptor specificity of the fibroblast growth factor family. J Biol Chem 1996;271:15292-7.
63. Oertel JE, Heffess CS, Oertel YC. Pancreas. In: Sternberg SS, ed. Diagnostic surgical pathology. New York: Raven Press, 1989: 1057-93.
64. Friess H, Yamanaka Y, Büchler M, et al. Increased expression of acidic and basic fibroblast growth factors in chronic pancreatitis. Am J Pathol 1994;144:117-28.
65. Ishiwata T, Kornmann M, Beger HG, Korc M. Enhanced fibroblast growth factor-5 expression in stromal and exocrine elements of the pancreas in chronic pancreatitis. Gut (in press).
66. Nguyen HQ, Danilenko DM, Bucay N, et al. Expression of keratinocyte growth factor in embryonic liver of transgenic mice causes changes in epithelial growth and differentiation resulting in polycyctic kidneys and other organ malformations. Oncogene 1996;12: 2109-19.
67. Hall M, Peters G. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res 1996;68:67-108.
68. Gansauge S, Gansauge F, Ramadani M, et al. Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. Cancer Res 1997;57:1634-7.
69. Kornmann M, Ishiwata T, Itakura J, Tangvoranuntakul P, Beger HG, Korc M. Increased cyclin D1 expression in human pancreatic cancer is associated with decreased postoperative survival. Oncology (in press).
70. Pizette S, Coulier F, Birnbaum D, DeLapeyriere O. FGF6 modulates the expression of fibroblast growth factor receptors and myogenic genes in muscle cells. Exp Cell Res 1996;224:143-51.
71. Yoshimura K, Eto H, Miyake H, Hara I, Arakawa S, Kamidono S. Messenger ribonucleic acids for fibroblast growth factors and their receptor in bladder and renal cell carcinoma cell lines. Cancer Lett 1996;103:91-7.